Big Food Companies Market 'GLP-1 Friendly' Diets Amid Obesity Medication Surge

Major food corporations are launching new product lines labeled 'GLP-1 Friendly' to capitalize on the popularity of obesity drugs like Ozempic and Wegovy. Nutritionists warn that these marketing campaigns may obscure the nutritional reality for consumers managing their weight with medication. This trend highlights the intersection of pharmaceutical innovation and corporate marketing strategies in the modern food industry.